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Surveillance of swine influenza A viruses (swIAV) allows timely detection and identification of new 
variants with potential zoonotic risks. In this study, we aimed to identify swIAV subtypes that 
circulated in pigs in Belgium and the Netherlands between 2014 and 2019, and characterize their 
genetic and antigenic evolution. We subtyped all isolates and analyzed hemagglutinin sequences and 
hemagglutination inhibition assay data for H1 swIAV, which were the dominant HA subtype. We also 
analyzed whole genome sequences (WGS) of selected isolates. Out of 200 samples, 89 tested positive 
for swIAV. swIAV of H1N1, H1N2 and H3N2 subtypes were detected. Analysis of WGS of 18 H1 swIAV 
isolates revealed three newly emerged genotypes. The European avian-like H1 swIAV (lineage 1C) 
were predominant and accounted for 47.2% of the total isolates. They were shown to evolve faster 
than the European human-like H1 (1B lineage) swIAV, which represented 27% of the isolates. The 2009 
pandemic H1 swIAV (lineage 1A) accounted for only 5.6% of the isolates and showed divergence from 
their precursor virus. These results point to the increasing divergence of swIAV and stress the need for 
continuous surveillance of swIAV.
Influenza A viruses of the H1N1, H1N2 and H3N2 subtypes circulate in pigs. Due to the geographical segregation 
of pig populations and multiple introductions of viruses from either humans or birds, swine influenza A viruses 
(swIAV) differ genetically and antigenically between continents and regions. The surface proteins of influenza 
viruses, the hemagglutinin (HA) and neuraminidase (NA), frequently undergo minor amino acid changes, or 
antigenic drift, resulting in the emergence of new  variants1. Also, due to their segmented genomes, influenza 
viruses are capable of exchanging genome segments by genetic reassortment, a process that results in new virus 
strains. As a result, multiple lineages of swIAV circulate globally.
Four major lineages of swIAV with HA genes from distinct origins are enzootic in swine in Europe. Avian 
H1N1 viruses were introduced to swine in 1979. They are thus referred to as ‘avian-like’ H1N1  viruses2,3 and 
their HA genes belong to lineage 1C in the global H1 classification  system4. H3N2 viruses emerged in 1984 after 
a reassortment between a human H3N2 virus related to A/Port Chalmers/1/1973 and the ‘avian-like’ swine H1N1 
virus. This resulted in a ‘human-like’ H3N2 virus with internal genes from the ‘avian-like’ H1N1  virus5–7. H1N2 
viruses were first reported in 1994 and were reassortants with the HA gene of a human seasonal H1N1 virus 
that was circulating in the mid-1980s and all other genes from the human-like swine H3N2 virus. They are thus 
referred to as the ‘human-like’ H1N2  viruses8 and their HA belongs to lineage  1B4. The 2009 pandemic H1N1 
viruses belong to the latest of the four major swIAV lineages in the European swine population. They are reas-
sortants comprising of gene segments from three major swIAV  lineages9,10. The HA segment was derived from 
the classical swine H1N1 lineage, which has been present in North American swine since 1918, and belongs to 
lineage  1A4. The neuraminidase (NA) and matrix (M) genes were derived from the European ‘avian-like’ H1N1 
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virus, whereas the five remaining internal gene segments originated from a North American triple reassortant 
H3N2 swIAV.
Swine influenza A viruses that circulate in Europe are genetically and antigenically distinct from those cir-
culating in other continents due to introductions from different origins and time points. In North America, five 
major lineages of swIAV circulate in pigs. The first lineage is the classical swine (lineage 1A) whose emergence 
coincided with the 1918 human pandemic that was caused by an H1N1  virus11,12. The second lineage emerged 
only in the late 1990s and consists of “triple” reassortant H3N2 viruses with surface proteins from a human H3N2 
virus and internal protein genes from the latter virus, as well as classical swine and avian viruses. The classical 
swine lineage viruses reassorted with this H3N2 virus, leading to the diversification of their HA. This led to the 
emergence of the α, β, and γ clades within the classical swine H1 lineage. In the early 2000s, viruses containing 
HA and/or NA derived from human seasonal H1N1 influenza viruses were introduced to pigs resulting in the 
third lineage of swIAV. Two clades emerged from this human seasonal-like H1 (lineage 1B) swIAV, the δ1 and 
δ2  clades13. The 2009 pandemic H1N1 viruses formed the fourth lineage of  swIAV11,12. The fifth lineage of swIAV 
emerged between 2010 and 2011 and it consists of viruses that acquired only the HA or both HA and NA from 
human H3N2 viruses that were circulating during this period. These are the so-called novel reassortant H3N2 
 viruses14. Currently, the predominant clades of H1 viruses in North America are the γ and δ1 clade viruses, which 
belong to lineages 1A and 1B  respectively4,15. The situation is more complex in Asia, with lineages of swIAV 
circulating in Europe and North America also circulating in this  continent16,17.
The four European lineages of swIAV have continued to evolve, either through further reassortment events 
or accumulation of mutations in their surface protein genes, resulting in the emergence of multiple genotypes 
and clades of influenza viruses. This prompted the formation of the then “European Surveillance Networks for 
Influenza in Pigs” (ESNIP 1, 2 and 3) between 2001 and  201318–21. Between 2009 and 2013, 23 genotypes of 
swIAV were identified and 6 of them were responsible for 77% of the reported cases in 14 countries. A more 
recent surveillance study in 17 European countries from 2015–201822 identified 16 more genotypes that had 
not been reported prior to the study. Notably, the 2009 pandemic H1N1 viruses were not detected in Belgium 
and the Netherlands, but reassortants containing their genes (HA and internal genes) were detected in the 
 Netherlands20–22. The introduction of the 2009 H1N1 pandemic virus into the swine population has resulted in 
increased reassortment, leading to an explosion of novel genotypes of  swIAV13,23–25.
There has been inconsistent surveillance of swIAV in swine populations worldwide, with uneven regional 
performance. Europe in particular, lags behind when compared to the USA. This could also be indicated partly 
by the differences in the amount of data from these two regions that are deposited in public sequence databases. 
In this study we aimed to: (1) Identify the subtypes and lineages of swIAV that circulated in swine in Belgium 
and the Netherlands from 2014 through 2019, (2) Determine the genotypes of the circulating viruses and explore 
possible introductions of genes from another continent, and (3) Genetically and antigenically characterize the 
predominant H1 swIAV subtype to better understand their evolutionary dynamics.
Materials and methods
Virus isolation and subtyping. Viruses were isolated from nasal swabs or lung tissues collected from 
pigs with influenza-like symptoms in Belgium and the Netherlands between 2014 and 2019. Virus isolation was 
done in Mardin-Darby Canine Kidney (MDCK) cells according to standard  procedures26. Upon a first passage 
in MDCK cells, viral RNA was extracted using the INDICAL BIOSCIENCE IndiSpin pathogen kit according to 
the manufacturer’s instructions, and subtyped by multiplex RT-qPCR as previously  described27.
Whole genome sequencing. Extracted RNA was amplified using Invitrogen Superscript III One-Step RT-
PCR with Platinum Taq (ThermoFisher Scientific, Waltham, USA) and influenza-specific  primers28 designed to 
bind to the conserved 3’ and 5’ ends of all segments. PCR products were purified using AMPure XP Magnetic 
Beads (Beckman Coulter, Fullerton, USA) and quantified with the NanoDrop™ 1000 Spectrophotometer (Ther-
moFisher Scientific). The Rapid Barcoding Kit (RBK-004, Oxford Nanopore Technology, Oxford, UK) was used 
to prepare libraries for the MinION platform as per the manufacturer’s instructions. Samples were loaded onto 
a FLO-MIN106 R9.4.1 flow cell as per the manufacturer’s instructions and a five-hour run was conducted with 
standard settings. The MinIT (MinKNOW v19.12.1) was used to perform real time basecalling, and integrated 
Guppy v3.2.9 (ONT) was used to produce FastQ files. Mapping and final consensus production of the quality 
checked and trimmed reads was conducted in the Geneious Software Suite (v11.1.5; Biomatters) with Bowtie2 
(v2.3.0 in the pre-set “Medium Sensitivity”), creating full genomes for all samples. Genotyping of the internal 
gene cassette was performed as previously  described22.
Genetic and antigenic characterization of the field isolates. We selected a total of 16 H1 swine and 
human influenza A viruses to use as reference viruses in the genetic and antigenic HA characterization of the 
isolates (Table 1). The viruses were selected to include historical and contemporary influenza strains that circu-
lated in pigs in Europe and North America, as well as in humans. The European swIAV were selected to represent 
the European H1 avian-like (EU H1av; 1C) and the European H1 human-like (EU H1hu; 1B.1) lineages with 
emphasis on the past (1982–1994) and more recent (1998–2012) strains. The North American swIAV on the 
other hand were selected to represent clades that currently circulate in swine, known by their colloquial names as 
H1-γ (1A.3.3.3) and H1-δ1 (1B.2.2) clade viruses, which in this study are referred to as US H1-γ and US H1-δ1 
clade viruses respectively. We also selected three human seasonal H1N1 viruses spanning 20 years of antigenic 
drift and two viruses representative of the 2009 H1N1 pandemic (H1pdm09) virus (1A.3.3.2).
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Genetic characterization of the HA of swIAV isolates. Full-length HA sequencing of virus isolates was 
partly performed at the Institute of Diagnostic Virology, Friedrich-Loeffler-Institut (FLI), Germany and partly 
at the Animal and Plant Health Agency (APHA), United Kingdom. The sequences were obtained by RT-qPCR 
as previously  described29. QIAquick gel extraction kit (Qiagen, Hilden, Germany) was used to purify amplicons 
generated from a 1.5% agarose gel. The amplicons were then Sanger-sequenced using the RT-PCR primers. 
Analysis of the sequences was performed on an ABI 310 sequencer. The sequences were then curated using the 
Chromas  Lite@ software http:// www. techn elysi um. com. au/ Chrom as250 Setup. exe) and assembled using CAP3 
programme (http:// doua. prabi. fr/ softw are/ cap3)27. The HA of the isolates were assigned to clades using the  tool4 
on the Influenza Research Database (IRD) at http:// fludb. org. The H1 numbering scheme described by Burke 
and Smith was  used30 To determine the genetic relationships between the virus isolates and the reference viruses, 
sequences were aligned with ClustalW and percentage amino acid (aa) identities in the HA1 and at antigenic 
 sites31,32 determined using MEGA 7.0.26  software33.
All generated sequences were deposited in GenBank and assigned accession numbers MW362568-MW362741.
For phylogenetic analysis, maximum-likelihood trees were constructed with the IQ-TREE web  server34. HA1 
amino acid sequences from clades 1A, 1B and 1C of H1 influenza A viruses were aligned using the MAFFT web 
bioinformatics framework (https:// mafft. cbrc. jp/ align ment/ softw are/)35. The constructed tree was presented 
and edited with FigTree V1.4.4 software (v1.4.4). The default Blosum62 substitution model was selected for the 
estimation of the amino acid substitution rates for both clade 1B and 1C viruses. Bayesian Markov chain Monte 
Carlo (MCMC) approach for Bayesian phylogenetic inference were performed with the BEAST package (version 
1.10.4) using the strict molecular clock model. The model was run for more than 3,000,000 generations with 
every 2,000 cycles sampled for both clades. The fitting clock-rate and virus population evolutionary rate for the 
two clades of swIAV were analyzed with Tracer1.6 software (version 1.7.1). Effective sampling size (ESS > 200) 
of each run was obtained.
Antigenic characterization of the HA of swIAV isolates. For antigenic characterization, virus iso-
lates passaged twice on MDCK cells were tested for cross-reactivity with hyperimmune swine or ferret sera 
against the selected reference viruses (Table 1) in hemagglutination inhibition (HI) assays, according to standard 
 procedures26. Briefly, sera were heat inactivated and then treated with receptor destroying enzyme (RDE) at 37 
°C for 18 h to remove non-specific inhibitors. Non-specific agglutinins were removed prior to HI assay by add-
ing 50% turkey red blood cells (TRBC). Tests were performed with two-fold serial dilutions of the sera, followed 
by incubation with 4 hemagglutinating units of virus for 1 h. TRBC at a concentration of 0.5% were added to 
the wells and incubated with the virus-serum mixtures for another 1 h. The reciprocal of the highest dilution of 
serum that completely inhibited hemagglutination was defined as the HI titer.
Using the HI data, a 3 dimensional (3D) antigenic map was constructed using the antigenic cartography soft-
ware (https:// acmacs- web. antig enic- carto graphy. org/). Antigenic distances were generated as raw data directly 
from the antigenic cartography software. The 3D cartographic projections were generated using ACMAS. Analysis 
Table 1.  Reference influenza A virus strains used for genetic and antigenic characterization of the 
hemagglutinin (HA) of swIAV isolates. EU H1av—European avian-like H1; EU H1hu—European human-like 
H1; H1pdm09—2009 pandemic H1; US H1γ—United States of America H1 gamma clade; US H1δ1—United 
States of America H1 delta 1 clade.
Virus strain Abbreviation Subtype
Colloquial name of the 
H1 virus H1 clade
GenBank HA accession 
no
A/swine/Fin-
estère/2899/1982 swFI82 H1N1 EU H1av 1C.1 CY116348
A/swine/Belgium/1/1998 swBE98 H1N1 EU H1av 1C.2 FJ805962
A/swine/Gent/132/2005 swG05 H1N1 EU H1av 1C.2.1 CY116434
A/swine/Gent/28/2010 swG10 H1N1 EU H1av 1C.2.1 KP406525
A/swine/Scot-
land/410,440/1994 swSC94 H1N2 EU H1hu 1B.1 AF085413
A/swine/Gent/7625/1999 swG99 H1N2 EU H1hu 1B.1.2.1 AY590823
A/swine/Gent/177/2002 swG02 H1N2 EU H1hu 1B.1.2.1 CY116442
A/swine/Gent/26/2012 swG12 H1N2 EU H1hu 1B.1.2.1 KP406526
A/California/04/2009 CA09 H1N1 H1pdm09 1A.3.3.2 FJ966082
A/Slovenia/2903/2015 SL15 H1N1 H1pdm09 1A.3.3.2 EPI768541
A/swine/Ohio/511,445/2007 swOH07 H1N1 US H1γ clade 1A.3.3.3 EU604689
A/swine/Illinois/
A0104020/2010 swIL10 H1N2 US H1δ1 clade 1B.2.2.2 JQ756323
A/swine/Alabama/
A01104091/2016 swAL16 H1N2 US H1δ1 clade 1B.2.2.1 KX247675
A/Taiwan/1/1986 TW86 H1N1 Human seasonal H1 Other-human 1B.2 X17224
A/New Caledonia/20/1999 NC99 H1N1 Human seasonal H1 Other-human 1B.2 DQ508857
A/Brisbane/59/2007 BR07 H1N1 Human seasonal H1 Other-human 1B.2 CY058487
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of the table vs map distance was then conducted. Antigenic distances are measured in antigenic units (AU) and 
1 AU is equivalent to a two-fold dilution in the HI assay.
The hyperimmune sera used in this study were produced against the selected reference viruses described 
and listed in Table 1. Different methods of production as well as different animal species (pigs and ferrets) were 
used. Antisera against the European H1 swIAV were produced in swine. For these, one influenza naïve pig per 
virus received two intramuscular vaccinations with ultra-violet light-inactivated monovalent whole virus vac-
cine (WIV) containing 256 hemagglutinating units (HAU) of virus in combination with an oil-in-water adjuvant 
(20% Emulsigen). The vaccines were administered 4-weeks apart. Blood was collected at the time of each vac-
cination and two weeks after the second vaccination, when a titer ≥ 160 was likely to have been achieved. Pigs 
were then humanely euthanised with sodium pentobarbital and large volumes of blood collected for serum. 
Antisera against the US H1γ and H1δ clade swIAV were generously provided by the United States Department 
of Agriculture (USDA). These were post-vaccination antisera that were produced in swine as described by Lewis 
et al.36. Antisera against the human viruses were generously provided by Dr. John McCauley of the Francis Crick 
Institute in London, United Kingdom. These were post-infection ferret sera.
The samples used in this study were obtained from pig holdings for routine veterinary diagnosis on respiratory 
diseases. Examination and reporting followed the standard business guidelines of Ghent University. No addi-
tional sampling was instigated on the basis of this study. Therefore, a separate ethical approval was not required.
Results
Subtyping of swIAV isolates. Out of the 200 samples that we received over the 6-year period, 89 tested 
positive for swIAV by virus isolation in MDCK cells (Table 2). Seventeen of these viruses were isolated from 
pigs in the Netherlands while the other 72 originated from pigs in Belgium. In total, there were 71 H1 and 18 
H3 swIAV isolates. Based on subtyping results, viruses with the EU H1av HA accounted for 47.2% of the total 
positive isolates while those with the EU H1hu and H3 HA accounted for 27.0 and 20.2%, respectively. Viruses 
with the H1pdm09 HA accounted for only 5.6% of the total isolates. The most dominant subtype was H1N1 (40 
out of 89 isolates) from the EU H1av lineage, followed by H1N2 (24 out of 89 isolates) from the EU H1hu lineage 
and H3N2 (18 out of 89 isolates) respectively. Only one isolate belonged to the 2009 pandemic H1N1 subtype. 
Six isolates were reassortants between the above-mentioned subtypes. Two of these were H1avN2, three were 
H1pdmN2 and one H1pdmN1 virus but with the NA derived from the EU H1av lineage. We could not identify 
two isolates by RT-qPCR due to insufficient RNA material. Based on cross-HI data (Supplementary Table S2 
online) and neuraminidase inhibition (NI) assay (Supplementary Table S6 online), they were characterized as 
H1huN2 (A/swine/Gent/175/2014) and H3N2 (A/swine/Gent/34/2014). H3 isolates were not further analyzed 
in this study.
Genotypic analysis. In total, 19 out of the 71 positive H1 isolates were selected for WGS. These included 
reassortant isolates as well as isolates that had a low signal in RT-qPCR. The isolates were selected for WGS on 
basis of subtype, date and location of origin so as to represent the full temporal, geographical and viral scope 
of the field sample collection. One sample, A/swine/Gent/55/2014, had low-coverage sequencing data and was 
therefore omitted from the analysis. Figure 1 shows genotypes of 18 H1 swIAV. As for the HA, these isolates 
belonged to different clades within the three H1 lineages: EU H1av (clade 1C.2.1 and 1C.2.2), EU H1hu (clade 
1B.1.2.1) and H1pdm09 (clade 1A.3.3.2). Isolates of the H1N2 subtype had their NA derived from the proto-
type EU H1hu virus A/swine/Scotland/410,440/1994 (swSC94-like N2), or from the human-like H3N2 virus 
A/swine/Gent/1/1984 (swG84-like N2) as previously  described21. Three out of the 18 sequenced isolates had 
genotypes (shown with red asterisk) that were not reported during the 2009–2013 influenza surveillance in 
Europe (Watson et al., 2015) and in the most recent surveillance study in  Europe22. Interestingly, all the EU H1av 
and the EU H1hu viruses retained the internal genes of avian origin except for the M gene which, in 17 out of 
Table 2.  Subtypes of swIAV isolated from pigs in Belgium and the Netherlands in the period 2014–2019. The 
three subtypes of swIAV that circulate in swine are shown in first column. Within each subtype, the lineages/
origin (second column) of the HA and NA are indicated: av—European avian-like; hu—European human-like; 
pdm—2009 pandemic.
Isolate subtype Isolate lineage
Number of isolates per year
2014 2015 2016 2017 2018 2019 Total
H1N1




H1huN2 5 1 1 8 9 24
H1avN2 1 1 2
H1pdmN2 1 2 3
H3N2 H3huN2 8 2 4 4 18
Number of positive samples 23 3 2 8 22 31 89
Total number of samples 51 11 3 24 58 53 200
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18 viruses, was of H1pdm09 origin. The H1pdm09 viruses seem to have been circulating in pigs over the 6-year 
period although the first isolation of a wholly H1pdm09 virus in Belgium was in 2019.
Genetic characterization of the HA of swIAV isolates. Due to sequencing failures (partial sequences), 
the HA sequences of three viruses (A/swine/Gent/55/2014, A/swine/Gent/93/2014, A/swine/Gent/175/2014) 
were not included in this analysis. We first identified the HA clade to which each isolate belonged (Supple-
mentary Table S4 online). As observed in the genotypic analysis, the HA of the EU H1av (lineage 1C) isolates 
belonged to two clades: 1C.2.1 (32 isolates) and 1C.2.2 (10 isolates). On the other hand, the HA of all the EU 
H1hu (lineage 1B) swIAV isolates belonged to clade 1B.1.2.1 (21 isolates). The HA of the H1pdm09 (lineage 1A) 
swIAV isolates belonged to clade 1A.3.3.2 (5 isolates). To characterize the evolution of the isolates, we compared 
aa identities in the HA1 domain of the HA genes of 68 isolates with those of historical and contemporary swIAV 
circulating in pigs in Europe and North America as well as human influenza viruses. A phylogenetic tree based 
on the HA1 sequences of the isolates and the reference viruses is shown in Fig. 2.
The HA1 contains the known immunodominant epitopes and the receptor binding  site31. The genetic relat-
edness of HA1 genes of the isolates and those of the reference viruses are shown in Supplementary Table S1 
online. Among the EU H1av viruses, the highest genetic diversity in the HA1 was observed between the isolates 
of both clades 1C.2.1 and 1C.2.2, and clade 1C.1 reference virus (% aa identity ≤ 88.7). Percentage aa identities 
with reference viruses belonging to clade 1C.2.1 and clade 1C.2.2 were higher, i.e. between 92.0 and 96.8 for 
clade 1C.2.1 isolates and between 91.1 and 95.1 for clade 1C.2.2 isolates. The EU H1hu isolates (clade 1B.1.2.1) 
showed varying genetic relationships with the EU H1hu reference viruses of clades 1B.1 (89.2–91.1% aa iden-
tity) and 1B.1.2.1 (87.5–96.0% aa identity). As expected, they were divergent from the US H1δ clades 1B.2.2.2 
(82.5–84.6% aa identity) and 1B.2.2.1 (80.4–82.5% aa identity) reference viruses. These viruses were also more 
divergent from the recent human seasonal viruses, NC99 and BR07 (82.8–87.4% aa identity) as compared with 
the past human seasonal virus, TW86 (89.0–90.5% aa identity). The human viruses (TW86, NC99, BR07) are 
classified as other-human 1B.2 according to the H1 classification  system4. Due to its close genetic relationship 
with the EU H1hu viruses (1B.1.2.1), and also for clear comparisons in this study, we show TW86 as belonging 
to 1B.1-like clade. We consider TW86 as the ancestor virus of the EU H1hu viruses. As expected, the H1pdm09 
isolates were more closely related to reference viruses of the same clade 1A.3.3.2 (88.7–97.2% aa identity) than 
to the US H1γ virus of clade 1A.3.3.3 (84.4–89.3% aa identity), which is their supposed precursor. However, out 
of the five H1pdm09 virus isolates, one strain was more divergent from reference viruses of the same clade. This 
virus shared only 88.7% aa identity with reference viruses, compared to 91.4–97.2% for the other four isolates. The 






































Figure 1.  Genotypes of 18 H1N1 and H1N2 swIAV isolated in Belgium and the Netherlands between 2014 and 
2019. The colour coding assigned to gene segments is based on their origin: green rectangle European avian-
like H1N1, magenta rectangle European human-like H1N2, dark blue rectangle 2009 pandemic H1N1, light 
blue rectangle human-like H3N2. The N2 of the isolates originated either from the European human-like H1N2 
lineage (swSC94-like; purple rectangle) or from the European human-like H3N2 lineage (swG84-like; light blue 
rectangle)21. The three viruses with new genotypes are shown with asterisks (*).
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but they were distant from H1 of reference viruses representing clades that only circulate in North America. Thus, 
there was no indication of a spillover of North American swIAV strains into the European swine population.
We also examined the genetic relatedness at antigenic sites between the virus isolates and the reference viruses. 
The HA1 of H1 influenza viruses contains receptor binding sites surrounded by five antigenic sites—Sa, Sb, Ca1, 
Ca2 and Cb—which contain 50 aa in  total31,37. We determined percentage aa identities among these 50 aa (Sup-
plementary Table S5 online). We observed a similar trend of genetic relatedness as that in the aa of the entire 
HA1, but percentage aa identities at antigenic sites were way lower than in the HA1 (Supplementary Table S1 
A-D online). This indicates that aa changes occur more frequently at antigenic sites.
We also evaluated the rate of aa substitution in the HA1 of H1 isolates. The substitution rates, as determined 

























































































Figure 2.  Phylogenetic tree of H1 swIAV isolates and reference viruses. HA1 amino acid sequences from clades 
1A, 1B and 1C of H1 influenza A viruses were aligned using the MAFFT web bioinformatics  framework35. The 
constructed tree was presented and edited with FigTree V1.4.4 software (v1.4.4). The names of the isolates are 
shown in black while those of the reference viruses are colored according to their lineages: EU H1av (green), EU 
H1hu (red), H1pdm09 (blue), US H1γ (light blue), US H1δ (orange), human H1 viruses (purple).
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year (95% highest posterior density (HPD): 3.18 ×  10–3, 5.02 ×  10–3), while the EU H1hu swIAV evolve at a mean 
rate of 3.76 ×  10–3 substitutions per site per year (95% HPD: 3.02 ×  10–3, 4.55 ×  10–3). This indicates that the mean 
rate of evolution of the EU H1av viruses is faster than that of the EU H1hu viruses. We could not determine the 
substitution rates of the H1pdm09 swIAV isolates because there were only five isolates in this group of viruses.
Antigenic characterization of the HA of swIAV isolates. To determine antigenic relationships within 
and between H1 swIAV lineages, we performed HI assays with 71 H1 swIAV isolates and antisera against 16 
historical and contemporary European and North American swIAV strains as well as human influenza A strains 
(Supplementary Table S2 online). There were 43 EU H1av isolates, 23 EU H1hu isolates and 5 H1pdm09 isolates. 
Using the obtained HI data, we generated a 3D antigenic map (Fig. 3). The swIAV isolates formed two anti-
genic clusters. The EU H1av isolates (light green spheres) clustered with EU H1av reference viruses (dark green 
spheres) as well as with the H1pdm09 (dark blue spheres) and US H1γ (blue spheres) reference viruses. On the 
other hand, the EU H1hu isolates (pink spheres) clustered with EU H1hu reference viruses (maroon spheres) 
and one human reference virus (purple sphere). All EU H1av isolates, regardless of the clade they belonged 
to, reacted with antisera against EU H1av reference viruses (HI titers ≥ 40). On the other hand, all EU H1hu 
isolates except for three isolates that failed to react with swSC94, reacted with antisera against EU H1hu refer-
ence viruses (HI titers ≥ 40). Low (HI titers ≤ 40) or no cross-reactivity was observed between viruses belonging 
to these two lineages. The EU H1av isolates also reacted with antisera against the H1pdm09 and the US H1γ 
reference viruses. However, all isolates (except 2) reacted with antisera against CA09 (H1pmd09) while only a 
few isolates, 12 and 7 out of 43, reacted with antisera against SL15 (H1pdm09) and OH07 (US H1γ) reference 
viruses respectively. There was low (HI titer ≤ 40) or no cross-reactivity between all the isolates and the US H1δ 
viruses (orange spheres) and human viruses (purple spheres) except for reactivity between the EU H1hu isolates 
and one past human virus, TW86 (HI titer ≥ 40 for 16 out of 23 isolates). Two of these isolates also had a titer of 
80 against NC99.
Antigenic distances from the reference viruses ranged between 0.7 to 7.0 AU within EU H1av and 0.4 to 
7.6 AU within EU H1hu isolates (Supplementary Table S3). On the other hand, antigenic distances within the 
H1pdm09 isolates ranged between 0.8 and 13.2 AU. Two out the five H1pdm09 isolates had antigenic distances 
ranging between 2.6 and 6.5 AU away from the EU H1av reference viruses, similar to what was observed within 
the EU H1av isolates. Their distances from the H1pdm09 reference viruses ranged between 0.8 and 2.1 AU. The 
other three were outliers (as shown on the map), with antigenic distances ranging between 6.7 and 13.2 AU from 
the EU H1av reference viruses and 4.8 to 13.3 from the H1pdm09 reference viruses.
Figure 3.  Antigenic diversity of H1 swIAV isolated in Belgium and the Netherlands in 2014–2019. A 3D map 
was constructed based on the reactivity of the isolates in HI assay, with sera against the reference viruses, which 
included: dark green sphere EU H1av, maroon sphere EU H1hu, dark blue sphere H1pdm09,  blue sphere US 
H1γ, orange sphere US H1δ1 and purple sphere Human H1. The H1 isolates are colored using lighter shades 
of the color of the reference viruses belonging to the same or related lineage: light green sphere EU H1av, pink 
sphere EU H1hu and light blue sphere H1pdm09. The virus strains are shown as spheres while the respective 
antisera are shown as semi-transparent cubes. Antigenic distances of the three H1pdm09 outliers from the 
H1pdm09 reference virus (CA09) are shown with red arrows. The squares in the grid represent antigenic 
distances. One square is equal to a two-fold change in HI titer, which is equal to 1 antigenic unit (AU). Analysis 
of the table vs map distance was conducted generating a moderately high  r2 score value  (r2 = 0.71).
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Overall, all isolates were antigenically divergent from the US H1δ viruses and the recent human viruses (NC99 
and BR07) as displayed on the map.
We retrieved antigenic distances from the antigenic map and examined distances of the EU H1av and EU 
H1hu isolates from their supposed ancestor viruses, swFI82 and TW86 respectively (Fig. 4). We observed more 
antigenic diversity from the ancestor virus within the EU H1av isolates (1.1 to 7.0 AU) as compared to the EU 
H1hu isolates (2.1 to 6.6 AU). The average evolution rates determined from antigenic distances between the 
ancestor viruses and viruses isolated in 2019, showed that the EU H1av isolates evolved at a rate of 0.15 AU per 
year while the EU H1hu isolates evolved at a rate of 0.10 AU per year. Taken together, these results suggest that 
the EU H1av viruses evolve at a slightly higher rate as compared to the EU H1hu viruses.
In order to explain the antigenic differences observed between viruses within the same lineage, we examined 
aa substitutions that have been previously considered important, and associated with antigenic  changes38–40. 
These included aa substitutions R43L, F71I, K141E, E153K, E155G, N156D, D187N, S271P and a deletion at aa 
position 130 (Δ130). Three of these aa positions (43, 130, 271) are located outside the antigenic sites. Among 
the EU H1av viruses, substitution E155G (13 out of 42 isolates) was observed between EU H1av reference virus, 
swFI82, and the isolates (Table 3). Ten of these isolates had antigenic distances ranging between 5.0 and 6.8 AU 
away from swFI82. Distances between the other three isolates and swFI82 were < 5.0 AU. Interestingly, two out of 
these three also had another common substitution, L71I. In total, 11 EU H1av isolates had the L71I substitution. 
For the EU H1hu isolates, there were no aa substitutions at these putative important positions when compared to 
TW86 or the EU H1hu reference viruses expect for two viruses. One virus had an aa substitution at position 141, 
while the other virus had a substitution at position 153. On the other hand, aa substitutions R43L, I71F, E141K, 



















































































Figure 4.  Antigenic distances of the EU H1av isolates (a) and EU H1hu isolates (b) from their ancestor viruses 
swFI82 and TW86 respectively. The virus isolates are shown in orange  circles while the reference viruses are 
colored differently; green circle EU H1av, magenta circle EU H1hu and grey circle Human H1.
Table 3.  Presence ( +) or absence (-) of important amino acid substitutions or deletion (Δ). Isolates of each 
lineage were compared with reference viruses belonging to the same lineage. Isolates belonging to the EU 
H1hu lineage were also compared with the US H1δ and past (TW86) and recent (NC99, BR07) human 
seasonal reference viruses due to their common origin. The symbol + /− is used where some isolates in the 
same lineage have the substitution while others do not. The number of isolates with the substitution are shown 
in brackets. In total, there were 42 EU H1av HA sequences, 21 EU H1hu and 5 H1pdm09 HA sequences. Iso—
isolates, Ref—reference viruses, hu—human viruses. The asterisks denote a different substitution; L71L for 
EU H1av and I71F for the EU H1hu isolates when compared to the US H1δ and the recent human reference 
viruses.
Substitution or deletion
Iso: EU H1av EU H1hu H1pdm09 EU H1hu
Ref: EU H1av EU H1hu H1pdm09 Past hu Recent hu US H1δ
R43L – – – –  +  + /− (16)
F/L71I  + /− *(11) – – –  + *  + *
Δ130 – – – – – –
K141E –  + /− (1) –  + /− (1)  +  + 
E153K –  + /− (1) –  + /− (1) – –
E155G  + /− (13) –  + /− (1) – – –
N156D – –  + /− (1) – – –
D187N/S – –  + /− (3) –  +  + 
S271P – –  + /− (1) –  +  + 
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substitutions were also observed with the recent human viruses NC99 and BR07. This could explain the anti-
genic differences observed between the EU H1hu isolates and US H1δ and the two more recent human viruses. 
Among the five H1pdm09 isolates, substitutions were observed in three of them: swG228/14 (E155G, D187S), 
swG220/19 (K43R, D187S) and swG235/19 (E155T, D187N). These three viruses were shown to be antigenically 
divergent from their 2009 precursor in the antigenic map. The most divergent H1pdm09 isolate, swG235/19, 
also had additional aa substitutions, N156D, which has been previously associated with antigenic  changes40.
Discussion
We isolated 89 swIAV from pigs in Belgium and the Netherlands between the year 2014 and 2019, mainly H1 
(71) and only a few H3 viruses (18). Because of the limited number of H3 viruses, we focused on the charac-
terization of H1 swIAV isolates. Most of these (47.2%) had an HA derived from the EU H1av (1C) lineage and 
could be divided into two clades; 1C.2.1 and 1C.2.2. We isolated fewer EU H1hu (1B) lineage viruses (27%) all 
belonging to clade 1B.1.2.1. Only a few isolates (5.6%) had an HA derived from the H1pdm09 (1A) lineage and 
they all belonged to clade 1A.3.3.2.
For the first time, we isolated viruses with HA derived from the H1pdm09 lineage from pigs in Belgium. In 
the Netherlands, however, reassortant viruses containing all genes except the NA from the H1pdm09 viruses have 
been reported since  201221,22. Reassortant EU H1av viruses containing the M gene from the H1pdm09 lineage 
were also detected in Belgium during this study period.
The predominance of the EU H1av viruses and low incidences of the H1pdm09 viruses have also been 
reported in countries across mainland  Europe21,22,41–44. The EU H1av swIAV were found in proportions ranging 
between 27.9% and 69.6% in these countries, while the H1pdm09 swIAV accounted for up to 9.1% of the circu-
lating strains. In the United Kingdom and the Republic of Ireland, in contrast, the H1pdm09 viruses circulate 
at high frequencies of 36% and 56.3%  respectively22.
Full-length genomes of 18 isolates revealed the presence of previously reported  genotypes21,22,43, with all except 
one virus containing the M gene from the H1pdm09 lineage. swIAV circulating in European pigs continue to 
exchange genes amongst each other resulting in second generation reassortants with different genotypes from 
their precursors. Especially, reassortants with the H1pdm09 viruses being on the rise, as these have also been 
reported in other studies. The three new genotypes of swIAV that were identified in this study resulted from the 
replacement of the M gene of the EU H1av viruses with that of the H1pdm09 virus. swIAV genotypes with the 
M gene from the H1pdm09 lineage have become established in swIAV throughout Europe. In fact, in the study 
by Henritzi and  colleagues22, EU H1av viruses carrying the M gene from the H1pdm09 had the second-highest 
prevalence of genome constellations. Experimental studies in guinea pig and ferret models have associated the 
M gene from the H1pdm09 viruses with efficient transmission of influenza  viruses45–47. Using reverse genetics to 
introduce the M gene of the H1pdm09 virus A/Netherlands/602/2009 into a background of A/Puerto Rico/8/1934 
(H1N1), Campbell and colleagues found an increase in NA activity. This H1pdm09 M-NA interaction is thought 
to lead to efficient transmission of influenza A  viruses45. In the United States, H3N2 variant (H3N2v) viruses 
that contained the M gene from the H1pdm09 virus caused human infections in 2011–201248 and in  201649,50. 
Although influenza variant viruses rarely result in sustained human-to-human transmissions, this raises concerns 
about the pandemic potential of these variant viruses. The role of the M gene from the H1pdm09 virus in H1 
swIAV therefore, needs to be explored further.
The antigenic evolution within both the EU H1av and the EU H1hu swIAV was observed to be slow, in that 
the antisera against the past reference viruses isolated as early as 1982 and 1986 still reacted with the viruses 
isolated in 2014–2019. Despite this, the rate of evolution of the EU H1av was slightly faster than that of the 
EU H1hu swIAV isolates, both at the antigenic level (0.15 AU per year vs 0.10 AU per year) and at the genetic 
level (4.06 ×  10–3 substitutions per site per year vs 3.76 ×  10–3 substitutions per site per year aa substitutions). 
Amino acid substitution E155G has been previously shown to affect receptor binding specificity of H1 influenza 
 viruses38,51,52. Most of the EU H1av isolates (10 out of 13) with this aa substitution had great antigenic distances 
(5.0–6.8 AU) from their ancestor virus. While this may not be the sole factor influencing the observed antigenic 
changes, we speculate that the role of this substitution in receptor binding specificity impacted HI results and 
hence the increased antigenic distances. The EU H1hu isolates and their human ancestor virus, on the other hand, 
shared the same aa among the ones considered important. Yet great antigenic distances were observed between 
the EU H1hu isolates and the US H1δ swIAV as well as the recent human viruses (NC99 and BR07). Interestingly, 
aa substitution F71I was observed between these viruses and the EU H1hu isolates. Amino acid substitution at 
position 71 has been shown to drive antigenic drift both in swine and human H1 influenza  viruses38,39, and could 
explain the antigenic distances observed. Three out of the five H1pdm09 isolates were antigenically divergent 
from the H1pdm09 reference viruses (4.8 – 12.9 AU). These three isolates shared aa substitutions at position 187 
(D187S or D187N). Substitution D187N has been shown to correlate with antigenic  changes38. Position 187 is 
also part of the receptor-binding  site53 meaning that these substitutions could influence receptor-binding capacity 
of these viruses and lead to changes in HI titers. This could possibly explain the observed antigenic divergence 
of the three isolates. An additional aa substitution was N156D, which was present in the isolate swG235/19, and 
has been associated with large changes in biophysical properties of the H1pdm09  viruses40. This substitution 
could be the reason why this isolate was antigenically different from the rest. Although the described amino 
acid substitutions, which are mainly from previous studies may have been the cause of the observed antigenic 
differences in this study, we cannot rule out the fact that other mutations that we observed but have not been 
previously described, also impacted the antigenicity of the isolates.
As explained earlier, introduction of swine viruses to humans poses a risk to public health. We recently 
reported a case of human infection with one of the EU H1av isolates from the current study, A/swine/Nether-
lands/Gent-193/2019 (Fig. 1) in a farmer in the  Netherlands54. What draws our attention is the lack of antibodies 
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against these viruses in the human population. A recent serological study showed that humans largely lack HI 
and virus neutralizing antibodies against the EU H1av swIAV, with seroprevalence rates against these viruses 
being ≤ 10%55. Henritzi and colleagues, in contrast, reported low neutralizing activity of human plasma against 
only a few strains of H1 avian-like viruses, while the majority of adult human sera revealed moderate to high 
 titers22. If these viruses would acquire the ability to replicate and transmit in humans, they would have consider-
able pandemic potential. Apart from the EU H1av viruses, the EU H1hu viruses may also pose a threat to humans. 
The antigenic clustering of the EU H1hu isolates with the oldest human H1 virus from 1986 and not with the 
more recent human H1 viruses isolated in 1999 or later, indicate a slow evolution of these human-derived viruses 
in swine. Swine, therefore, serve as reservoirs for the past viruses that ceased to circulate in humans. Over the 
years, the human population immunity against these swIAV will gradually decrease. Because the younger human 
population will be lacking immunity against the circulating swIAV that were initially introduced from humans, 
there will be an increased chance of re-introduction of these viruses into humans. Although re-introduction of a 
virus to a population that lacks immunity rarely results in a pandemic, such a possibility cannot be ignored. This 
was illustrated by the 2009 pandemic virus. This virus inherited its HA from a North American swIAV, which is 
a descendant of the 1918 pandemic H1N1 virus. In 2009, only humans born before 1930–40 had cross-reactive 
antibodies against the new pandemic virus, so the virus could easily spread among the younger  population56. 
Such a scenario could occur in the future with other swIAV, if these viruses will manage to adapt to, replicate 
and become transmissible in humans. The results of this study stress the importance of frequent surveillance of 
swIAV, as well as monitoring of the evolution of these viruses for better preparedness in the event of a pandemic.
Data availability
Nucleic acid sequences generated during this study are available in the GenBank repository and have been 
assigned accession numbers MW362568-MW362741. . Data generated or analyzed during this study are included 
in this article and as supplementary information.
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